Clinical Trial Update: Aripiprazole Augmentation Therapy in Treatment-resistant Depression [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of aripiprazole augmentation for treatment-resistant depression was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Therapy-resistant Depression

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: University Hospital Freiburg | Conditions: Therapy-resistant Depression | Phase 3 | Status: WITHDRAWN